
Urinary tract infections (UTIs), especially cystitis, are a common yet painful reality for one in two women at some point in their lives. Many women face these infections repeatedly, posing a significant challenge for healthcare providers.
The growing problem of antibiotics not working because the bacteria are becoming resistant is making it harder for doctors to treat these infections effectively.
Traditionally, figuring out the exact bacteria responsible for a UTI takes days, which delays the right treatment.
But there’s exciting news from the world of science. Researchers from ETH Zurich and Balgrist University Hospital have made a groundbreaking advancement. They’ve created a fast test for UTIs using bacteriophages, which are viruses that hunt bacteria.
What’s more, these phages have been genetically tweaked to be even better at finding and destroying bacteria. This innovative work has been shared in Nature Communications.
Bacteriophages, or phages for short, are naturally occurring viruses that attack specific bacteria.
The team, led by Professor Martin Loessner of ETH Zurich, selected phages that target the three main culprits behind UTIs: Escherichia coli, Klebsiella, and Enterococci.
They then engineered these phages so that when they infect the bacteria, the bacteria light up, making them easy to spot.
This new method can identify the bacteria causing a UTI from a urine sample in less than four hours, which could drastically change how quickly effective treatments are started, helping to avoid the misuse of antibiotics.
Phage therapy isn’t new; it’s been around for over a century but was overshadowed by antibiotics like penicillin. However, as antibiotic resistance becomes a bigger issue, the interest in phages has reignited.
Phages are like precision missiles, targeting only specific bacteria without harming others.
The ETH Zurich researchers went a step further, modifying the phages to not only reproduce within the bacteria but also to make bacteriocins, proteins that are toxic to bacteria. This one-two punch makes the therapy even more powerful.
The next step for this promising therapy is clinical trials with patients, to be conducted by the ETH Zurich team and their partners at Balgrist University Hospital. Matthew Dunne, one of the study’s leading authors, mentions that this is just the beginning.
There’s a growing number of studies exploring how natural and genetically modified phages can be used in treatment.
However, he notes that before these therapies can be widely adopted in Western medicine, there’s a need for extensive clinical trials and changes in regulatory policies to accommodate the unique nature of phages.
This breakthrough could herald a new era in the fight against UTIs, offering a more targeted and effective treatment option that also addresses the critical issue of antibiotic resistance.
If you care about inflammation, please read studies about the big cause of inflammation in common bowel disease, and vitamin B may help fight COVID-19 and reduce inflammation.
For more information about nutrition, please see recent studies about new way to halt excessive inflammation, and results showing foods that could cause inflammation.
Copyright © 2024 Knowridge Science Report. All rights reserved.